Modern Diagnostic & Research Centre IPO Subscription Status
The Modern Diagnostic & Research Centre IPO has been subscribed 350.49x times overall. Retail investors have shown interest with bids for 342.46x the shares available. The Non-Institutional Investor (NII) category has been subscribed 519.38x. Qualified Institutional Buyers (QIBs) have subscribed 193.51x. Data last updated on 13 Apr, 07:44 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 31 Dec, 2025 and closes on 02 Jan, 2026. The shares are expected to list on stock exchanges on 07 Jan, 2026.
Table of Contents
Live Bidding
| Category | Offered | Applied | Bid Details | TIMES |
|---|---|---|---|---|
|
QIB
|
7,82,400 | 15,14,00,000 |
15,14,00,000
of 7,82,400
|
193.51x |
|
NII
|
7,92,000 | 41,13,45,600 |
41,13,45,600
of 7,92,000
|
519.38x |
|
Retail
|
13,63,200 | 46,68,44,800 |
46,68,44,800
of 13,63,200
|
342.46x |
| TOTAL | 29,37,600 | 1,02,95,90,400 |
1,02,95,90,400
-
|
350.49x |
Last Updated: 13 Apr 2026, 07:44 PM
Retail Allotment
High demand detected. The retail category is heavily oversubscribed, making the allotment a lottery where only 1 out of every 343 applicants will be successful.
Institutional Backing
Massive institutional interest with QIBs subscribing 193.51x. This often signals long-term confidence from professional funds.
Day-wise Subscription History
Subscription trends over the last 5 days
| Date | Total | ||
|---|---|---|---|
|
13 Apr 2026
DAY 5
|
350.49x
|
||
|
QIB
193.51x
NII
519.38x
Retail
342.46x
|
|||
|
21 Jan 2026
DAY 4
|
350.49x
|
||
|
QIB
193.51x
NII
519.38x
Retail
342.46x
|
|||
|
02 Jan 2026
DAY 3
|
376.90x
|
||
|
QIB
193.51x
NII
702.08x
Retail
342.46x
|
|||
|
01 Jan 2026
DAY 2
|
30.87x
|
||
|
QIB
8.94x
NII
53.22x
Retail
33.85x
|
|||
|
31 Dec 2025
DAY 1
|
5.60x
|
||
|
QIB
4.01x
NII
7.96x
Retail
5.51x
|
|||
IPO Guru on Android
Get live GMP alerts, subscription updates, and allotment status directly on your phone. Fast, Free, and Secure.
Modern Diagnostic & Research Centre IPO Allotment Probability
Allotment probability is calculated based on current subscription multiples. Retail allotment is by lottery when oversubscribed; NII allotment is proportionate. Final numbers may change until subscription closes. This is not investment advice.
What Does This Subscription Data Mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during market hours (10 AM – 5 PM IST) on active subscription days.
Frequently Asked Questions
What is the current subscription status of Modern Diagnostic & Research Centre IPO?
As of IPO close date (02 Jan, 2026), the Modern Diagnostic & Research Centre IPO is subscribed 350.49x times. Retail category is 342.46x, and NII is 519.38x subscribed.
When is the allotment date for Modern Diagnostic & Research Centre IPO?
The allotment for Modern Diagnostic & Research Centre IPO is expected to be finalized on 05 January, 2026.
What is the GMP of Modern Diagnostic & Research Centre?
The Grey Market Premium (GMP) for Modern Diagnostic & Research Centre is currently ₹14, indicating a potential listing gain of 16%.
When will Modern Diagnostic & Research Centre IPO list on the stock market?
Modern Diagnostic & Research Centre is scheduled to list on BSE and NSE on 07 January, 2026.
What are the chances of getting allotment in Modern Diagnostic & Research Centre IPO?
The retail category is oversubscribed at 342.46x, meaning allotment is by lottery. Statistically, approximately 1 in 343 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 193.51x mean for Modern Diagnostic & Research Centre IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 193.51x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Modern Diagnostic & Research Centre IPO allotment status?
After the allotment date (05 Jan, 2026), you can check your Modern Diagnostic & Research Centre IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Modern Diagnostic & Research Centre IPO Further
Track every stage of this IPO from subscription to listing:
Discussion 0
No comments yet
Be the first to share your thoughts!